221 related articles for article (PubMed ID: 12418961)
21. Protein complexes bearing myc-like antigenicity recognize two distinct DNA sequences.
Negishi Y; Iguchi-Ariga SM; Ariga H
Oncogene; 1992 Mar; 7(3):543-8. PubMed ID: 1549367
[TBL] [Abstract][Full Text] [Related]
22. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
23. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
25. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
26. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
27. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
28. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
[TBL] [Abstract][Full Text] [Related]
29. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
30. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
31. A transcriptional repressor of c-myc.
Kakkis E; Riggs KJ; Gillespie W; Calame K
Nature; 1989 Jun; 339(6227):718-21. PubMed ID: 2662014
[TBL] [Abstract][Full Text] [Related]
32. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome.
Toyo-oka K; Hirotsune S; Gambello MJ; Zhou ZQ; Olson L; Rosenfeld MG; Eisenman R; Hurlin P; Wynshaw-Boris A
Hum Mol Genet; 2004 May; 13(10):1057-67. PubMed ID: 15028671
[TBL] [Abstract][Full Text] [Related]
33. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
34. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman D; Elkind NB; Roy B; Beamon J; Rotter V
Cell Growth Differ; 1993 Feb; 4(2):57-65. PubMed ID: 8494784
[TBL] [Abstract][Full Text] [Related]
35. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
36. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
[TBL] [Abstract][Full Text] [Related]
37. Cell growth suppression by thanatos-associated protein 11(THAP11) is mediated by transcriptional downregulation of c-Myc.
Zhu CY; Li CY; Li Y; Zhan YQ; Li YH; Xu CW; Xu WX; Sun HB; Yang XM
Cell Death Differ; 2009 Mar; 16(3):395-405. PubMed ID: 19008924
[TBL] [Abstract][Full Text] [Related]
38. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
39. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
40. Ketogenic HMGCS2 Is a c-Myc target gene expressed in differentiated cells of human colonic epithelium and down-regulated in colon cancer.
Camarero N; Mascaró C; Mayordomo C; Vilardell F; Haro D; Marrero PF
Mol Cancer Res; 2006 Sep; 4(9):645-53. PubMed ID: 16940161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
